1-6 of 6
Anders Österborg, MD
Close
Sort by
Journal Articles

Dishevelled Proteins of Wnt Signaling Pathways Are Highly Expressed in Chronic Lymphocytic Leukemia

Abdul Salam Khan, Åsa Sandin, Anders Österborg, MD, PhD, Mohammad Hojjat-Farsangi, Håkan Mellstedt, MD, PhD, Ali Moshfegh, PhD
Journal: Blood
Blood (2012) 120 (21): 4583.
https://doi.org/10.1182/blood.V120.21.4583.4583
Published: 2012
Journal Articles

Monoclonal Antibody Against ROR1 in Chronic Lymphocytic Leukemia Cells Induced Apoptosis Via PI3-Kinase/AKT/CREB Pathway

Amir Hossein Daneshmanesh, MD, PhD, Mohammad Hojjat-Farsangi, PhD, Asa Sandin, PhD, Abdul Salam Khan, Msc, Ali Moshfegh, PhD, Mahmood Jeddi-Tehrani, PhD, Anders Österborg, MD, PhD, Håkan Mellstedt, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1769.
https://doi.org/10.1182/blood.V120.21.1769.1769
Published: 2012
Journal Articles

Primary Mediastinal B Cell Lymphoma Treated with CHOP-Like Chemotherapy with or without Rituximab: 5-Year Results of the Mabthera International Trial Group (MInT) Study

Mathias Witzens-Harig, MD, Anthony D Ho, MD, Evelyn Kuhnt, Marek Trneny, MD, Michael Rieger, MD, Anders Österborg, MD, PhD, Ruth Pettengell, Robert Stevens, MD, Devinder S Gill, MB ChB, MRCP (UK), FRCPath (Lond), Jan Walewski, Markus Loeffler, Michael Pfreundschuh, MD
Journal: Blood
Blood (2012) 120 (21): 1612.
https://doi.org/10.1182/blood.V120.21.1612.1612
Published: 2012
Journal Articles

Ror1 Targeting Monoclonal Antibodies Induced Apoptosis of Chronic Lymphocytic Leukemia Cells– A Potential Novel Therapeutic Approach

Hodjattallah Rabbani, PhD, Amir Hossein Daneshmanesh, MD, Abdul Salam Khan, MSc, Mohammad Hojjat-Farsangi, PhD, Mahmood Jeddi-Tehrani, PhD, Mohammad Mehdi Akhondi, PhD, Anders Österborg, MD, PhD, Fazel Shokri, PhD, Håakan Mellstedt, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 916.
https://doi.org/10.1182/blood.V116.21.916.916
Published: 2010
Journal Articles

Final Analysis From the International Trial of Single-Agent Ofatumumab In Patients with Fludarabine-Refractory Chronic Lymphocytic Leukemia

William G. Wierda, MD, PhD, Thomas J. Kipps, MD, PhD, Jiri Mayer, MD, PhD, Tadeusz Robak, MD, PhD, Martin JS Dyer, MA, DPhil, FRCP, FRCPath, Richard R. Furman, MD, Peter Hillmen, MBChB, FRCP, FRCPath, PhD, Stephan Stilgenbauer, M.D., Catherine D. Williams, FRCPath, Marek Trneny, MD, PhD, Guillaume Cartron, MD, PhD, Francisco J. Hernandez-Ilizaliturri, MD, Swaminathan Padmanabhan, MBBS, MS, Geoffrey W. Chan, MD, Ira V. Gupta, MD, Michele M. Gorczyca, MS, Randy L. Davis, DrPH, Nedjad Losic, MSc, Steen Lisby, MD, DMSC, Anders Österborg, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 921.
https://doi.org/10.1182/blood.V116.21.921.921
Published: 2010
Journal Articles

Current Practice In Diagnosis and Treatment of Chemotherapy-Induced Anemia In Five European Countries – A Patient Record Study

Yves Beguin, MD, PhD, Matti Aapro, MD, Carsten Bokemeyer, MD, John Glaspy, MD, Michael Hedenus, MD, Timothy James Littlewood, MD, FRCP, Heinz Ludwig, MD, Anders Österborg, MD, Daniell Mitchell, PhD
Journal: Blood
Blood (2010) 116 (21): 1512.
https://doi.org/10.1182/blood.V116.21.1512.1512
Published: 2010